skip to Main Content

‘Biomarker-Based Chemotherapy Prolongs Pancreatic Cancer Patients’ Survival Time’

Newsfeed image, light gray text on dark gray background
A Seoul National University Bundang Hospital (SNUBH) research team has extended the survival period of pancreatic cancer patients after surgery with tailored adjuvant chemotherapy based on individual biomarkers.

The research team, led by Professor Hwang Jin-hyeok of the Internal Medicine Department, attempted to prove the effects of “customized anticancer therapy based on biomarkers” by planning a study that allows for selecting supplementary anticancer therapy after pancreatic surgery based on the individual patients’ expression of biomarkers. Read more . . . 


Back To Top